PharmaLex
↗Mannheim, Germany (Hans-Thoma-Straße 22, 68163 Mannheim) / Bad Homburg, Germany
PharmaLex is a leading global provider of specialized consulting, regulatory affairs, and pharmacovigilance services for the pharmaceutical, biotech, and medical device industries. The company supports clients throughout the entire product lifecycle from clinical development to marketing authorization to post-launch activities. As a Contract Research Organization (CRO), PharmaLex provides expert guidance on navigating regulatory pathways, managing CMC (Chemistry, Manufacturing, and Controls) documentation, conducting clinical trials, and ensuring drug safety compliance. The company is NOT a pharmaceutical manufacturer with its own drug pipeline, but rather a service provider helping pharma and biotech companies develop and commercialize their own products. Founded in 1994 in Mannheim, Germany, PharmaLex has grown to become one of the world's largest regulatory consulting firms with global reach across 32 countries and 67+ offices serving 1,600+ clients worldwide.
CLASSIFICATION
Company Type:CRO
Industry:Pharmaceutical Services | Contract Research Organization (CRO)
Sub-Industry:Regulatory Affairs Consulting | Pharmacovigilance | Scientific & Technical Writing | CMC/Quality Management
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$169M-$1B (estimates vary by source)
Founded:1994
Ownership:subsidiary
Status:acquired
FUNDING
Stage:Post-acquisition (private subsidiary of public parent)
Total Raised:$1.29B (acquisition price)
Investors:Cencora/AmerisourceBergen, Previously: AUCTUS Capital Partners AG
STOCK
Exchange:NASDAQ
Ticker:CEA
PIPELINE
Stage:N/A - Service Provider (not drug developer)
Lead Drug Stage:N/A - PharmaLex does not develop drugs
Modalities:Small molecule, Monoclonal antibodies (mAbs), Antibody-drug conjugates (ADCs), Cell therapy, Gene therapy, RNA therapies, Vaccines, Biosimilars
Trial Phases:-
CORPORATE STRUCTURE
Parent Company:Cencora, Inc. (NASDAQ: CEA)
Acquired By:Cencora (formerly AmerisourceBergen Corporation) (2022-09-12)
Subsidiaries:PharmaLex GmbH, Cencora PharmaLex (regional entities)
Key Partnerships:Cencora - Parent company providing integrated pharma solutions platform, Pharma/Biotech clients - 1,600+ satisfied clients including 9 of 10 top pharmaceutical companies, Health Authorities - FDA, EMA, and regulatory agencies globally, Academic institutions - Collaborations on clinical research and scientific advancement
COMPETITION
Position:Leader
Competitors:Parexel, Charles River Laboratories, Indegene, ProPharma Group, Zuellig Pharma, Alira Health, BlueReg, Celerion +5 more
LEADERSHIP
Key Executives:
Dr. Thomas Dobmeyer - Chief Executive Officer
Daniel Koppers - Vice President, Digital Innovation and Automation
John Lockwood - Sr. Director, Head of Medical Devices/IVDs, Americas
Scientific Founders:Founded 1994 - specific founders not identified in public sources
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of PharmaLex and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with PharmaLex. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.